Irritancy and allergic responses induced by topical application of ortho-phthalaldehyde

Toxicological Sciences

Volumn 115, Issue 2, 2010, Pages 435-443

  Anderson, Stacey E ^a   Umbright, Christina ^a   Sellamuthu, Rajendran ^a   Fluharty, Kara ^a   Kashon, Michael ^a   Franko, Jennifer ^a   Jackson, Laurel G ^a   Johnson, Victor J ^a   Joseph, Pius ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Asthma; Hypersensitivity; IgE; OPA

Indexed keywords

CD45 ANTIGEN; GLUTARALDEHYDE; IMMUNOGLOBULIN E; INTERLEUKIN 4; MESSENGER RNA; PHTHALALDEHYDE;

ARTICLE; CELL POPULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EAR SWELLING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERSENSITIVITY; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; LYMPH NODE; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PROTEIN EXPRESSION; SKIN IRRITATION; SKIN SENSITIZATION; SWELLING;

ADMINISTRATION, TOPICAL; ALLERGENS; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DERMATITIS, ALLERGIC CONTACT; DISINFECTANTS; DRUG THERAPY, COMBINATION; EAR, EXTERNAL; EPIDERMIS; FEMALE; HUMANS; IMMUNOGLOBULIN E; IRRITANTS; LOCAL LYMPH NODE ASSAY; LYMPH NODES; MICE; MICE, INBRED BALB C; O-PHTHALALDEHYDE;

MUS;

EID: 77954059891     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq054     Document Type: Article

References (36)

1. Azadi, S., Klink, K. J., and Meade, B. J. (2004). Divergent immunological responses following glutaraldehyde exposure. Toxicol. Appl. Pharmacol. 197, 1-8.
2. Basketter, D. A., Lea, L. J., Dickens, A., Briggs, D., Pate, I., Dearman, R. J., and Kimber, I. (1999). A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. J. Appl. Toxicol. 19, 261-266.
3. Butler, J. E. (2000). Enzyme-linked immunosorbent assay. J. Immunoassay 21, 165-209.
4. ChemicalLand 21 (Undated). o-Phthaladehyde. Available at: http://www.chemicalland21.com/specialtychem/perchem/o-PHTHALALDEHYDE.htm. Accessed August 19, 2009.
5. Franchi, A., and Franco, G. (2005). Evidence-based decision making in an endoscopy nurse with respiratory symptoms exposed to the new orthophthalaldehyde (OPA) disinfectant. Occup. Med. (Lond) 55, 575-578.
6. Fujita, H., Ogawa, M., and Endo, Y. (2006). A case of occupational bronchial asthma and contact dermatitis caused by ortho-phthalaldehyde exposure in a medical worker. J. Occup. Health 48, 413-416.
7. Fukuyama, T., Tajima, Y., Ueda, H., Hayashi, K., Shutoh, Y., Harada, T., and Kosaka, T. (2009). Allergic reaction induced by dermal and/or respiratory exposure to low-dose phenoxyacetic acid, organophosphorus, and carbamate pesticides. Toxicology 261, 152-161.
8. Gannon, P. F., Bright, P., Campbell, M., O'Hickey, S. P., and Burge, P. S. (1995). Occupational asthma due to glutaraldehyde and formaldehyde in endoscopy and x ray departments. Thorax 50, 156-159.
9. Hasegawa, G., Morinaga, T., and Ishihara, Y. (2009). Ortho-Phthalaldehyde enhances allergen-specific IgE production without allergen-specific IgG in ovalbumin-sensitized mice. Toxicol. Lett. 185, 45-50.
10. Herrick, C. A., Xu, L., Wisnewski, A. V., Das, J., Redlich, C. A., and Bottomly, K. (2002). A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. J. Allergy Clin. Immunol. 109, 873-878.
11. Howell, M. D., Weissman, D. N., and Meade, B. J. (2002). Latex sensitization by dermal exposure can lead to airway hyperreactivity. Int. Arch. Allergy Immunol. 28, 204-211.
12. Jarvis, J., Seed, M. J., Elton, R., Sawyer, L., Agius, R., and Ishihara, Y. (2005). Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds. Occup. Environ. Med. 62, 243-250.
13. Klink, K. J., and Meade, B. J. (2003). Dermal exposure to 3-amino-5-mercapto1,2,4-triazole (AMT) induces sensitization and airway hyperreactivity in BALB/c mice. Toxicol. Sci. 75, 89-98.
14. Kogevinas, M., Zock, J. P., et al. (2007). Exposure to substances in the workplace and new-onset asthma: an international prospective populationbased study (ECRHS-II). Lancet 370, 336-341.
15. Lerones, C., Mariscal, A., Carnero, M., Garcia-Rodriguez, A., and FernandezCrehuet, J. (2004). Assessing the residual antibacterial activity of clinical materials disinfected with glutaraldehyde, o-phthalaldehyde, hydrogen peroxide or 2-bromo-2-nitro-1,3-propanediol by means of a bacterial toxicity assay. Clin. Microbiol. Infect. 10, 984-989.
16. Manetz, T. S., and Meade, B. J. (1999). Development of a flow cytometry assay for the identification and differentiation of chemicals with the potential to elicit irritation, IgE-mediated, or T cell-mediated hypersensitivity responses. Toxicol. Sci. 48, 206-217.
17. National Institute of Environmental Health Sciences (NIEHS). (1999). The murine local lymph node assay: a test method for assessing the allergic contact dermatitis potential of chemicals/compounds. Fed. Regist. 64, 14006-14007.
18. TM (EPI-200), and the Rat Skin Transcutaneous Electrical Resistance (TER) Assay: In Vitro Test Methods for Assessing Dermal Corrosivity Potential of Chemicals. NIH Publication No: 02-4502.
19. National Institute for Occupational Safety and Health (NIOSH). (1990). National Occupational Exposure Survey (NOES) 1981-1983. Estimated Number of Employees Potentially Exposed to Specific Agents by Occupation with 2-Digit Standard industrial Classification (SIC).
20. Occupational Health and Safety Administration (OSHA). (2006). Best Practices for the Safe Use of Glutaraldehyde in Health Care. U.S. Department of Labor, OSHA 3258-08N.
21. Petsonk, E. L., Wang, M. L., Lewis, D. M., Siegel, P. D., and Husberg, B. J. (2000). Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest 118, 1183-1193.
22. Rideout, K., Teschke, K., Dimich-Ward, H., and Kennedy, S. M. (2005). Considering risks to healthcare workers from glutaraldehyde alternatives in high-level disinfection. J. Hosp. Infect. 59, 4-11.
23. Snapper, C. M., Finkelman, F. D., and Paul, W. E. (1988a). Regulation of IgG1 and IgE production by interleukin 4. Immunol. Rev. 102, 51-75.
24. 2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140, 2121-2127.
25. Sokol, W. N. (2004). Nine episodes of anaphylaxis following cystoscopy caused by Cidex OPA (ortho-phthalaldehyde) high-level disinfectant in 4 patients after cytoscopy. J. Allergy Clin. Immunol. 114, 392-397.
26. Suzukawa, M., Komiya, A., Koketsu, R., Kawakami, A., Kimura, M., Nito, T., Yamamoto, K., and Yamaguchi, M. (2007). Three cases of orthophthalaldehyde-induced anaphylaxis after laryngoscopy: detection of specific IgE in serum. Allergol. Int. 56, 313-316.
27. Suzukawa, M., Yamaguchi, M., Komiya, A., Kimura, M., Nito, T., and Yomamoto, K. (2006). Ortho-phthalaldehyde-induced anaphylaxis after laryngoscopy. J. Allergy Clin. Immunol. 117, 1500-1501.
28. Tucker, S. P. (2008). Determination of ortho-phthalaldehyde in air and on surfaces. J. Environ. Monit. 10, 1337-1349.
29. U.S. Environmental Protection Agency (USEPA). (2001). Method 531.2. Measurement of n-Methylcarbamyoloximes and n-Methylcarbamates in Water by Direct Aqueous Injection HPLC with Postcolumn Derivatization. EPA #815-B-01-002. Available at: http://www.epa.gov//safewater/methods/pdfs/methods/met531_2.pdf. Accessed August 19, 2009.
30. U.S. Environmental Protection Agency (USEPA). (2006). Inventory Update Rule. Office of Pollution, Prevention and Toxics, USEPA. [Search by cas no. for 643798]. Available at: http://www.epa.gov/oppt/iur/tools/data/2002-vol.htm. Accessed August 19, 2009.
31. U.S. Food and Drug Administration (USFDA). (2006). Device Evaluation Information: FDA Cleared Sterilants and High Level Disinfectants with General Claims for Processing Reusable Medical and Dental Devices: September 28, 2006. FDA, Center for Devices and Radiological Health (CDRH). Available at: http://www.fda.gov/cdrh/ode/germlab.html. Accessed August 19, 2009. Last updated on June 16, 2009.
32. Waters, A., Beach, J., and Abramson, M. (2003). Symptoms and lung function in health care personnel exposed to glutaraldehyde. Am. J. Ind. Med. 43, 196-203.
33. Wild, L. G., and Lopez, M. (2003). Occupational asthma caused by highmolecular-weight substances. Immunol. Allergy Clin. North Am. 23, 235-250.
34. Woolhiser, M. R., Munson, A. E., and Meade, B. J. (1999). Role of sensitization routes in the development of type I hypersensitivity to natural rubber latex in mice. Am. J. Ind. Med. (Suppl. 1), 139-141.
35. Woolhiser, M. R., Munson, A. E., and Meade, B. J. (2000). Comparison of mouse strains using the local lymph node assay. Toxicology 146, 221-227.
36. Zhang, X. D., Fedan, J. S., Lewis, D. M., and Siegel, P. D. (2004). Asthmalike biphasic airway responses in Brown Norway rats sensitized by dermal exposure to dry trimellitic anhydride powder. J. Allergy Clin. Immunol. 113, 320-326.